Thomas P. Cappola

faculty photo
Herbert C. Rorer Professor in Medical Sciences
Attending, Hospital of the University of Pennsylvania, Heart Failure and Transplantation Service
Member, Penn Cardiovascular Institute
Member, Institute for Diabetes, Obesity, and Metabolism
Member, Institute for Translational Medicine and Therapeutics
Member, Penn Genome Frontiers Institute
Programmatic Mentor, Masters in Translational Research Program, University of Pennsylvania Perelman School of Medicine
Chief, Division of Cardiovascular Medicine, University of Pennsylvania Perelman School of Medicine
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
Division of Cardiovascular Medicine
11-113 South Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-662-3140
Fax: 215-349-8017
Lab: 215-573-4717
Graduate Group Affiliations
Education:
A.B. (Chemistry)
Princeton University, 1991.
M.D. (Medicine)
Harvard Medical School, 1995.
Sc.M. (Clinical Investigation )
Johns Hopkins Bloomberg School of Public Health, 2004.
Permanent link
 

Description of Research Expertise

My laboratory uses clinical investigation and applied genomics to reveal mechanisms of human heart failure. This has included establishing a multicenter cohort study of advanced heart failure (Penn Heart Failure Study; PHFS) and a multicenter consortium for human myocardial transcriptomics and eQTL mapping (Myocardial Applied Genomics Network; MAGNet). Notable discoveries include the first demonstration that peripheral blood gene expression provides a clinical biomarker to track cardiac allograft rejection, identification of abnormalities in forkhead signaling and neuregulin signaling in common forms of human heart failure, and discovery of the 1p36 HSPB7/CLCNKA locus as the first bonafide genetic risk factor for non-familial heart failure. More recent work focuses on investigational therapeutics for heart failure. In my clinical role I treat patients with advanced heart failure on the inpatient and outpatient heart failure/transplant service.

Description of Itmat Expertise

Dr. Cappola studies mechanisms of human heart failure using genomics, biomakers, and proof-of-concept clinical trials. He directs the Adult Clinical and Translational Research Center.

Selected Publications

Chirinos JA, Londono-Hoyos F, Zamani P, Beraun M, Haines P, Vasim I, Varakantam S, Phan TS, Cappola TP, Margulies KB, Townsend RR, Segers P: Effects of organic and inorganic nitrate on aortic and carotid hemodynamics in heart failure and preserved ejection fraction. Eur J Heart Fail Page: epub, May 2017.

Wild P, Janine Felix, Schillert A, Teumer A, Cappola TP, Hirschhorn J, Mitchell GF, Smith N, Fox ER, Dueker ND, Jaddoe VW, Melander O, Russ M, Lehtimäki T, Ciullo M, Hicks A, Lind L, Gudnason V, Pieske B, Barron AJ, Zweiker R, Schunkert H, Ingelsson E, Liu K, Arnett DK, Psaty B, Blankenberg S, Larson M, Felix S, Franco OH, Zeller T, Vasan R, Dörr M: Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. JCI 127(5): 1798-1812, May 2017.

de Denus S, Rouleau J, Mann D, Huggins G, Naveen P, Shah S, Cappola TP, Fouodjio R, Mongrain M, Dubé : CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction. Pharmacogenomics J Page: epub, Apr 2017.

Esslinger U, Garnier S, Korniat A, Proust C, Kararigas G, Müller-Nurasyid M, Empana JP, Morley MP, Perret C, Stark K, Bick AG, Prasad SK, Kriebel J, Li J, Tiret L, Strauch K, O'Regan DP, Marguiles KB, Seidman JG, Boutouyrie P, Lacolley P, Jouven X, Hengstenberg C, Komajda M, Hakonarson H, Isnard R, Arbustini E, Grallert H, Cook SA, Seidman CE, Regitz-Zagrosek V, Cappola TP, Charron P, Cambien F, Villard E: Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy. PLoS One 12(3): e0172995, Mar 2017.

Dubin RF, Deo R, Bansal N, Anderson AH, Yang P, Go AS, Keane M, Townsend R, Porter A, Budoff M, Malik S, He J, Rahman M, Wright J, Cappola TP, Kallem R, Roy J, Sha D, Shlipak MG: Associations of conventional echocardiographic measures with incident heart failure and mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol 12(1): 60-68, Jan 2017.

Zamani P, Tan V, Soto-Calderon H, Beraun M, Brandimarto JA, Trieu L, Varakantam S, Doulias P, Townsend RR, Chittams J, Margulies KB, Cappola TP, Poole DC, Ischiropoulos H, Chirinos JA: Pharmacokinetics and Pharmacodynamics of Inorganic Nitrate in Heart Failure With Preserved Ejection Fraction. Circ Research Dec 2016 Notes: In Press.

Zamani P, French B, Brandimarto JA; Douliasm P, Javaheri A, Chirinos JA, Margulies KB, Townsend RR, Sweitzer NK, Fang JC; Ischiropoulos H, Cappola TP: Effect of heart failure with preserved ejection fraction on nitric oxide metabolites. Am J Cardiol 118(12): 1855-1860, Dec 2016.

Chirinos JA, Akers SR, Trieu L; Ischiropoulos H, Paschalis-Thomas D, Tariq A, Vassim I, Maheswara KR, Syed AA, Soto-Calderon H, Townsend RR Cappola TP, Margulies KB, Zamani P: Heart failure, left ventricular remodeling, and circulating nitric oxide metabolites. J Am Heart Assoc 5(10): e004133, Oct 2016.

Margulies KB, Hernandez A, Redfield M, Givertz M, Oliveira G, Cole R, Mann D, Whellan D, Kiernan M, Felker GM, McNulty S, Anstrom K, Shah S, Eugene Braunwald E, Cappola TP: Effects of liraglutide on clinical stability in advanced heart failure with reduced ejection fraction: a randomized clinical trial. JAMA 316(5): 500-508, Aug 2016.

AbouEzzeddine OF, French B, Mirzoyev SA, Jaffe AS, Levy WC, Fang JC, Sweitzer NK, Cappola TP, Redfield MM: From statistical significance to clinical relevance: a simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure. J Heart Lung Transplant 35(6): 714-21, Jun 2016 Notes: Epub 2016 Jan 15.

back to top
Last updated: 09/13/2017
The Trustees of the University of Pennsylvania